4.9
肺水肿是指液体在肺间质和肺泡腔积聚,从而影响气体交换和氧输送。肺水肿可分为心源性和非心源性,但两者都会降低氧合水平和肺顺应性。
心源性肺水肿
心源性肺水肿由肺毛细血管内静水压升高所致,通常是由于心肌梗死、心力衰竭或心脏瓣膜病引起的左心室功能障碍。心脏泵血无效会导致血液回流并淤积于肺循环,从而升高静脉…
心源性肺水肿通常始于左心室功能障碍,如心力衰竭中所见。
这会升高肺毛细血管中的静水压,导致液体从毛细血管净向移动至间质腔隙,并使肺泡发生水肿。
另一方面,在非心源性肺水肿中,主要机制是毛细血管通透性增加,通常由急性呼吸窘迫综合征或有毒物质吸入所引发。
富含蛋白质的液体渗入肺泡,通过渗透作用吸引更多水分进入。
在这两种情况下,肺泡液会破坏表面活性物质,增加表面张力,降低肺顺应性,从而使呼吸更加困难。由于扩散距离增加以及通气/血流比例失调,气体交换功能下降。
若不及时治疗,肺水肿可能进展为呼吸衰竭,其特征为严重的呼吸困难或气短;低氧血症或血液中氧气含量降低;以及高碳酸血症或二氧化碳水平升高。
View the full transcript and gain access to JoVE Core videos
Q1: What causes cardiogenic pulmonary edema?
Cardiogenic pulmonary edema results from left ventricular dysfunction, commonly seen in heart failure, myocardial infarction, or valvular disease. This dysfunction raises hydrostatic pressure in pulmonary capillaries, disrupting the balance between hydrostatic and oncotic forces. Fluid moves from capillaries into interstitial and alveolar spaces, impairing gas exchange and causing hypoxemia and dyspnea.
Q2: How does noncardiogenic pulmonary edema develop differently from cardiogenic edema?
Noncardiogenic edema occurs with normal hydrostatic pressure but increased capillary permeability due to injury or inflammation of the alveolar-capillary membrane. Conditions like acute respiratory distress syndrome or toxic inhalation damage endothelial barriers, allowing protein-rich fluid to leak into alveoli. This high-protein fluid draws in additional water osmotically, worsening edema without cardiac dysfunction.
Q3: How does pulmonary edema affect lung compliance and breathing?
Fluid accumulation in alveoli disrupts surfactant, increases surface tension, and reduces lung compliance, making alveolar expansion difficult. Increased diffusion distance and ventilation-perfusion mismatch further impair gas exchange. These changes force the respiratory muscles to work harder, increasing breathing effort and contributing to dyspnea and reduced oxygenation.
Q4: What are the severe complications of untreated pulmonary edema?
Untreated pulmonary edema can progress to acute respiratory failure, characterized by severe dyspnea, hypoxemia (low blood oxygen), and hypercapnia (elevated carbon dioxide). Fluid-filled alveoli cannot participate in gas exchange, leading to refractory hypoxemia. Prompt identification of the underlying cause is critical, as cardiogenic and noncardiogenic edema require distinct treatment strategies to restore adequate gas exchange.
Q5: Why does protein-rich fluid worsen noncardiogenic pulmonary edema?
In noncardiogenic edema, damaged alveolar-capillary membranes allow protein-rich fluid to leak into alveoli. The high protein concentration creates an osmotic gradient that draws additional water into the alveolar space, amplifying fluid accumulation. This mechanism differs from cardiogenic edema, where hydrostatic pressure drives fluid movement without significant protein leakage.
Q6: How does pulmonary edema impair gas exchange?
Fluid-filled alveoli cannot participate in gas exchange, increasing the diffusion distance between blood and air. Ventilation-perfusion mismatch occurs when fluid blocks ventilation to perfused areas. Together, these changes reduce oxygen uptake and carbon dioxide elimination, causing hypoxemia and hypercapnia that characterize respiratory failure if severe.
Q7: Why is distinguishing between cardiogenic and noncardiogenic edema important for treatment?
Cardiogenic and noncardiogenic pulmonary edema require distinct treatment strategies because they result from different pathophysiologic mechanisms. Cardiogenic edema stems from left ventricular dysfunction and elevated hydrostatic pressure, while noncardiogenic edema involves increased capillary permeability. Patients with respiratory complications may also benefit from understanding chronic obstructive pulmonary disease clinical manifestations to recognize overlapping symptoms.